From the publishers of JADPRO

Acute Lymphoblastic Leukemia Resource Center

Advertisement

Quality of life trajectories in children aged 2-4 years with acute lymphoblastic leukemia

Last Updated: Tuesday, February 25, 2025

This study investigates the quality of life in toddlers aged 2–4 years with acute lymphoblastic leukemia in Vietnam. Researchers used the PedsQL Generic Core Scales and Cancer Module to collect proxy reports from 104 participants, totaling 152 repeated measurements. The study found that physical, emotional, and social scores improved over the first three years post-diagnosis. However, anxiety about medical procedures was frequent in the first 1.5 years but gradually improved. Higher proxy education correlated with lower emotional domain scores, while fathers as proxies reported higher emotional domain scores but lower worry about medical procedures in their children.

 

European Journal of Pediatrics
Advertisement
News & Literature Highlights

Discover Oncology

Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: A case series and literature review

Frontiers in Oncology

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: A step towards addressing healthcare disparities in vulnerable populations from Southern Mexico

Clinical and Experimental Pediatrics

Allogeneic stem-cell transplantation following chimeric antigen receptor T-cell therapy for treatment of relapsed/ refractory hematologic malignancy in children and young adults: a systematic review and meta-analysis

Medical Journal, Armed Forces India

Bone mineral density in childhood acute lymphoblastic leukaemia survivors and factors affecting it

Blood Advances

Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

Pediatrics International: Official Journal of the Japan Pediatric Society

Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities

BMC Ophthalmology

Daratumumab-induced acute angle closure glaucoma: bone marrow transplantation as a possible risk factor and atropinization as a potential solution

Leukemia

Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: A single-center, single-arm, phase 2 trial

Cancer

Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Clinical Laboratory

T-acute lymphoblastic leukemia/lymphoma manifesting as acute renal failure

Advertisement
Advertisement